Epigenomic profiling of cerebrospinal fluid cells identifies immune regulatory alterations and implicates protocadherins in multiple sclerosis

This study utilizes whole-genome DNA methylation profiling of cerebrospinal fluid cells to reveal immune regulatory alterations in multiple sclerosis, highlighting a novel pathogenic role for protocadherin genes in T cell activation and migration.

The Gist

The Big Picture: The "Brain's Security Log"

Imagine your body is a massive castle. Multiple Sclerosis (MS) is like a security breach where your own immune system (the castle guards) mistakenly attacks the castle walls (your brain and nerves).

Usually, scientists study the guards while they are still in the barracks (your blood). But this paper argues that to understand the real trouble, we need to look at the guards who have already breached the castle and are patrolling the inner courtyard. That "inner courtyard" is the Cerebrospinal Fluid (CSF)—the liquid that surrounds your brain and spinal cord.

The researchers took a deep dive into the DNA of these specific brain-patrolling cells to see what "instructions" had been changed. They weren't looking at the DNA code itself (which is the hardware), but at the epigenome—the sticky notes, highlighters, and bookmarks attached to the DNA that tell the cell which instructions to read and which to ignore.

The Main Findings: What They Discovered

1. The "Traffic Jam" Instructions

The researchers found that in MS patients, the cells in the brain fluid had changed their "traffic rules."

• The Analogy: Imagine the immune cells are delivery trucks. In a healthy person, the trucks follow a map that keeps them in the right neighborhoods. In MS patients, the "sticky notes" on the DNA told the trucks to ignore the "Do Not Enter" signs and drive straight into the brain.
• The Science: They found thousands of changes in DNA methylation (the sticky notes) on genes responsible for adhesion and migration. These cells were epigenetically programmed to stick to blood vessel walls and squeeze through into the brain more easily than they should.

2. The "Switch" Flipped Wrong

The study looked at how these methylation changes affected the actual work the cells were doing (gene expression).

• The Analogy: Think of DNA as a library of books. Methylation is like putting a "Do Not Read" sticker on a book cover.
  • In MS, they found that books about calming the immune system (anti-inflammatory) had "Do Not Read" stickers slapped on them (hypermethylation), so the cells stopped making the calming chemicals.
  • Conversely, books about attacking and moving (pro-inflammatory) had the stickers removed (hypomethylation), so the cells went into overdrive.
• The Result: The cells in the brain were essentially "revved up" engines, ready to cause damage, while the brakes were cut.

3. The Mystery Guest: Protocadherins (The "Neural ID Cards")

This is the most exciting and surprising part of the paper.

• The Analogy: Protocadherins (PCDHs) are like a specific type of ID card or name tag. Scientists have always known these ID cards are worn by neurons (brain cells) to help them connect to each other and build the brain's wiring. They were never thought to be worn by immune cells (the guards).
• The Discovery: The researchers found that in MS patients, the immune cells in the brain were wearing these "Neural ID cards," but the instructions to make them were being shut down (silenced by methylation).
• Why it matters: It's like finding a police officer wearing a firefighter's helmet. It suggests that in MS, the immune system is somehow "confused" or trying to mimic brain cells. This might be a way the immune system is trying to communicate with the brain, but it's going wrong.

4. The "Master Switch" Connection

The paper connects these weird ID cards to a larger system called the Aryl Hydrocarbon Receptor (AHR).

• The Analogy: Think of AHR as a universal remote control for the immune system. This remote picks up signals from your environment—like pollution, diet, viruses (like the Epstein-Barr virus), and even smoking.
• The Connection: The study suggests that when you smoke or get infected with a virus, it flips the AHR switch. This switch then messes with the "Neural ID cards" (Protocadherins) and the "traffic rules" (migration genes). This creates a perfect storm where the immune system gets confused, attacks the brain, and the brain's own wiring gets disrupted.

Why This Matters

1. It's Not Just About Genetics:
You might have the "bad genes" for MS, but you don't get the disease unless something flips the switches. This paper shows exactly how environmental factors (like smoking or viruses) can flip those switches via DNA methylation.

2. New Targets for Medicine:
Currently, MS drugs are like "sledgehammers"—they knock out the whole immune system to stop the attack. This research suggests we could build "smart bombs."

• If we can fix the "traffic rules" (migration genes), we can stop the cells from entering the brain without killing them.
• If we can understand how the "Neural ID cards" (Protocadherins) work, we might find a way to stop the immune system from getting confused in the first place.

Summary in One Sentence

This study looked at the "instruction manuals" of immune cells inside the brains of MS patients and found that environmental factors have scrambled the instructions, causing the cells to become hyper-aggressive intruders and mistakenly wear "brain cell" ID tags, suggesting new ways to fix the communication breakdown between the immune system and the brain.

Technical Summary

1. Problem Statement

Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) driven by autoreactive T cells. While genetic and environmental risk factors (e.g., EBV, smoking, vitamin D deficiency) are known, the molecular mechanisms linking these factors to pathogenic immune activity remain incompletely understood.

• Limitations of Previous Studies: Most epigenetic studies in MS have focused on peripheral blood mononuclear cells (PBMCs). However, pathogenic T cells in MS are often rare in the periphery and may not reflect the compartmentalized immune responses occurring within the CNS.
• Gap: There is a lack of comprehensive genome-wide DNA methylation data from cerebrospinal fluid (CSF) cells, which directly reflect active neuroinflammation and are enriched for pathogenic T cells. Furthermore, the role of non-neuronal genes, such as protocadherins, in immune regulation within MS is unexplored.

2. Methodology

The study employed a multi-omics approach integrating whole-genome DNA methylation profiling, transcriptomics, and functional validation.

• Cohorts:
  • Discovery Cohort: 5 Relapsing-Remitting MS (RRMS) patients and 5 Non-Inflammatory Neurological Disease Controls (NINDC).
  • Validation Cohort: An expanded independent cohort of 18 RRMS, 7 NINDC, and 5 Inflammatory Neurological Disease Controls (INDC).
  • Technical Replicates: Shallow sequencing was performed on the discovery samples to validate deep sequencing data.
• Sequencing Strategy:
  • PBAT-seq (Post-Bisulfite Adaptor Tagging): Used for low-input samples (~5,000 cells) to generate whole-genome bisulfite sequencing (WGBS) data. This method minimizes DNA loss, crucial for limited CSF samples.
  • RNA-seq: Performed on overlapping donors to correlate methylation with gene expression.
  • External Data Integration: Utilized Affymetrix microarray data from a larger independent cohort, International Human Epigenome Consortium (IHEC) chromatin state annotations, and sorted T-cell subset datasets.
• Bioinformatic Analysis:
  • Differential Methylation: Identified Differentially Methylated Positions (DMPs) and Regions (DMRs) using three complementary statistical frameworks: Limma, MethylKit, and RADmeth.
  • Cell-Type Deconvolution: Used EpiDISH to estimate immune cell proportions (T cells, B cells, monocytes) from methylation profiles.
  • Functional Enrichment: Ingenuity Pathway Analysis (IPA) and GeneSetCluster were used to map DMPs/DMRs to pathways and upstream regulators.
  • Chromatin State Mapping: Integrated IHEC data to map MS-associated methylation changes to specific T-cell subset chromatin states (e.g., enhancers, bivalent promoters).
  • Validation: Flow cytometry was used to detect Protocadherin (PCDH) protein expression in peripheral T cells.

3. Key Contributions

• First Comprehensive CSF Methylome: Generated the first genome-wide DNA methylation map of CSF-infiltrating immune cells in MS, overcoming the challenge of low DNA input.
• Integration of Epigenetics and Transcriptomics: Demonstrated that methylation changes in CSF cells are functionally linked to gene expression alterations, specifically in immune regulatory pathways.
• Discovery of Protocadherins in Immunity: Identified a novel, widespread dysregulation of Protocadherin (PCDH) genes in MS immune cells, challenging the dogma that these are exclusively neuronal adhesion molecules.
• Mechanistic Link to AHR Signaling: Proposed a mechanistic axis linking PCDH dysregulation, $\gamma$-secretase signaling, and Aryl Hydrocarbon Receptor (AHR) pathways, connecting environmental cues to immune dysfunction.

4. Key Results

A. Global Methylation Landscape

• Differential Methylation: Identified 2,710 DMPs and 4,330 DMRs distinguishing RRMS from controls.
• Directionality: The majority (74%) of DMRs were hypermethylated in MS, particularly in promoter regions, suggesting transcriptional repression.
• Robustness: 74.8% of DMPs were replicated in an independent biological cohort, confirming the stability of these signatures.
• Cell Composition: CSF cells were predominantly T cells (mostly memory CD4+). No significant differences in overall cell proportions were found between groups, indicating that methylation changes are intrinsic to the cells rather than due to compositional shifts.

B. Functional Pathways

• Immune Migration and Adhesion: DMPs/DMRs were enriched in genes related to GPCR signaling, Rho GTPases, and cell adhesion.
  • Example: CCR7 (chemokine receptor) showed promoter hypomethylation (upregulation), while CXCR4 ligands were implicated in BBB transmigration.
  • Example: RAC2 (cytoskeletal remodeling) was hypomethylated and upregulated, supporting enhanced T-cell motility.
• Th17/Treg Balance:
  • Hypomethylation (activation) was observed in pro-inflammatory genes (e.g., TBX21, IL32, IL1RAP).
  • Hypermethylation (repression) was observed in regulatory genes (e.g., TGFBR3, IL10RA, RXRA), suggesting a shift toward pathogenic Th1/Th17 responses and away from regulatory T-cell (Treg) function.

C. Chromatin State Specificity

• MS-associated methylation changes were not random but enriched in specific regulatory elements:
  • Th17 Cells: Changes mapped primarily to active enhancers.
  • Other T Cells: Changes mapped to bivalent enhancers and Polycomb-repressed regions.
• The Cohesin Chromatin Regulation pathway was significantly enriched, particularly involving Protocadherin (PCDH) genes.

D. The Protocadherin (PCDH) Discovery

• Widespread Dysregulation: 43 distinct PCDH genes (mostly $\gamma$-cluster) showed consistent hypermethylation and downregulation in MS CSF cells.
• Expression in T Cells: Contrary to the belief that PCDHs are neuronal-only, RNA-seq and flow cytometry confirmed that PCDH$\gamma$ proteins are expressed in human T cells (specifically naive and TEMRA subsets).
• Co-expression Network: PCDH genes co-expressed with transcription factors and signaling molecules involved in Aryl Hydrocarbon Receptor (AHR) signaling.
• Mechanism: The study suggests that PCDH intracellular domains, released via $\gamma$-secretase cleavage, may translocate to the nucleus to regulate gene expression. Dysregulation of this pathway (evidenced by altered methylation of PCDHs and $\gamma$-secretase subunits like PSEN1) may disrupt 3D chromatin organization and AHR signaling.

E. Environmental Connection

• The AHR pathway integrates environmental signals (e.g., smoking, diet, EBV).
• AHRR (AHR repressor) showed promoter hypomethylation in MS, consistent with smoking-induced upregulation. This suggests PCDH dysregulation may serve as a molecular bridge between environmental exposures and immune dysregulation in MS.

5. Significance

• Pathogenic Insight: The study provides evidence that MS pathogenic T cells in the CNS are epigenetically "primed" for enhanced migration and adhesion, driven by specific methylation changes in enhancers and promoters.
• Novel Therapeutic Targets: The identification of PCDHs as immune regulators opens a new avenue for research. Targeting the PCDH-$\gamma$-secretase-AHR axis could offer new strategies for modulating T-cell activation and migration.
• Biomarker Potential: The specific methylation signatures in CSF cells could serve as biomarkers for disease activity or treatment response, distinct from peripheral blood markers.
• Methodological Advance: Demonstrates the feasibility and value of low-input PBAT-seq for clinical CSF samples, setting a precedent for future epigenomic studies in rare cell populations.

In summary, this paper redefines the understanding of MS immunopathology by revealing that epigenetic dysregulation in CSF T cells drives a pro-inflammatory, migratory phenotype, with a surprising and critical role for neuronal adhesion molecules (protocadherins) in this process.